Faculty

KB

Dr. Krista Baerg (Associate Member)

Pediatric Outpatient Department
(306) 844-1076
dr.kbaerg@usask.ca

Dr. Krista Baerg is a consultant pediatrician and associate professor of pediatrics at the University of Saskatchewan and is the physician lead of the Interdisciplinary Pediatric Complex Pain Clinic. She is the local principal investigator for the Chronic Pain Network, a CIHR SPOR chronic disease network and an active member of the Pediatric Pain Interprofessional Practice Council and Newborn Jaundice Working Group for Saskatchewan children’s services. Dr. Baerg’s research focuses on Complex Regional Pain Syndrome, chronic pain, pediatric pain management, and Interprofessional collaboration.

Dr. Lane Bekar  (Neuroscience Cluster Executive)
Department of Pharmacology
(306)-966-1201
lane.bekar@usask.ca

Dr. Bekar’s work focuses on characterizing the role of inflammation, stress, and diet on neurodegenerative processes in non-transgenic mice. Interests: Alzheimer’s; Parkinson’s; neurodegeneration; inflammation; stress; high sucrose diet.

Recent Publications

Dr. Veronica Campanucci
Department of Physiology
(306) 966-5934
veronica.campanucci@usask.ca

Dr. Campanucci explores the impact of diabetes and chronic inflammation on the nervous system. Interests: diabetes; patch-clamp electrophysiology; live imaging in vitro; inflammation; transgenic mice; mitochondrial morphology and traffic.

Recent Publications

Dr. Francisco Cayabyab (Neuroscience Cluster Leader)
Department of Surgery 
(306) 966-8191
frank.cayabyab@usask.ca

Dr. Cayabyab works on adenosine receptor signaling in neurological diseases, and the biology of breast cancer and brain cancer.  Interests: stroke; Parkinsons's disease; epilepsy; neurophysiology; confocal imaging; biochemistry; synaptic plasticity and behavior.

Recent Publications

Dr. Jennifer Chlan
Department of Anatomy & Cell Biology
(306) 966-6557
jen.chlan@usask.ca

Dr. Chlan’s research focuses on the neurodevelopment of schizophrenia and Autism, the neuropathology of Alzheimer's Disease, and educational research. Interests: neurodevelopment; molecular neuropsychiatry; neuroanatomy.

Recent Publications

Dr. John Howland
Department of Physiology
(306) 966-2032
john.howland@usask.ca

Dr. Howland’s behavioural neuroscience laboratory is interested in animal models of schizophrenia, learning and memory, behavioural and electrophysiological effects of stress, limbic-cortical interactions, synaptic plasticity, epilepsy.

Recent Publications

mk

Dr. Michael Kelly
Department of Surgery - Neurosurgery Division

Before joining the Division of Neurosurgery at the University of Saskatchewan, Dr. Kelly Held fellowships at the Cleveland Clinic and Stanford University.  At the UofS, his research includes use of Synchrotron Imaging of animal stroke models, assessing neurobiology of motor recovery after stroke using fMRI, and several clinical trials evaluating the efficacy of endovascular stent retrieval of cerebral blood clots.

rl

Dr. Robert Laprairie (Associate Member)
College of Pharmacy and Nutrition
(306) 966-6301
robert.laprairie@usask.ca

Dr. Laprairie’s molecular pharmacology laboratory is focused on the discovery and development of drugs targeting the cannabinoid receptors - the same receptors that are activated by ∆9-tetrahydrocannabinol (THC) from Cannabis. These cannabinoid drugs are derived from synthetic and natural sources and may be useful for the treatment of pain, anxiety, epilepsy, and movement disorders.

Recent Publications

ML

Dr. Michael Levin
Department of Neurology
(306) 655-8350
michael.levin@usask.ca

The long-term goal of research in the Levin Lab is to better understand the cause of neurodegeneration, a salient feature and cause of permanent disability in progressive multiple sclerosis (MS) patients. For more than 20 years, we have studied the function of the RNA binding protein heterogeneous nuclear ribonuclear protein A1 (hnRNP A1 -‘A1’), with a focus on ‘M9’. M9 is A1’s nucleocytoplasmic transport domain, and is required for transport of A1 between the nucleus and cytoplasm. Our lab has discovered that MS patients make antibodies to M9 and the brains and lymphocytes of MS patients contain somatic DNA mutations within M9

Dr. Ivar Mendez
Department of Surgery
(306) 966-8641
ivar.mendez@usask.ca

Dr. Mendez’ research focus is in brain repair, functional neurosurgery, robotic neurosurgery and computerized systems in neurosurgical applications. Interests: Parkinson’s disease; stem cells; robotics; neuromodulation.

Recent Publications

Dr. Darrell Mousseau (Neuroscience Cluster Executive)
Department of Psychiatry
(306) 966-8824
darrell.mousseau@usask.ca

Dr. Mousseau’s goal is to identify the neurochemical and biochemical overlaps between depression and Alzheimer's disease. Interests: monoaminergic dysfunctions in brain and peripheral tissues; Alzheimer's disease; breast cancer; prostate cancer.

Recent Publications

Dr. Sean Mulligan
Department of Physiology
(306) 966-2422
sean.mulligan@usask.ca

Dr. Mulligan is interested in the mechanisms of peripheral pain signaling, pain pathophysiology, analgesia, ethics of animal research, animal sentience, and consciousness.

Recent Publications

Dr. Phyllis Paterson (Neuroscience Cluster Executive)
College of Pharmacy & Nutrition
(306) 966-5838
phyllis.paterson@usask.ca

Dr. Paterson studies the role of nutrition in enhancing recovery mechanisms after stroke. Interests: nutrition; stroke; global brain ischemia; neuroinflammation; neuroplasticity; synchrotron-based techniques for brain imaging.

Recent Publications 

lp

Dr. Lissa Peeling
Department of Surgery - Neurosurgery Division

Before joining the Division of Neurosurgery at the University of Saskatchewan, Dr. Peeling held fellowship at Stony Brook University Medical Centre, in Endovascular and Cerebrovascular Neurosurgery. She has an MD and a B.Sc. in Physiology both from the University of Saskatchewan. Her current research interests include using the Synchrotron Facility at UofS to develop high resolution imaging to assess blood flow in cerebral aneurysms.

Dr. Alex Rajput
Department of Medicine-Neurology
(306) 844-1411
alex.rajput@usask.ca

Dr. Rajput’s primary research employs analysis of frozen human brain tissue, clinicopathological correlations, genetics, and neurochemistry to examine movement disorders. Interests: Parkinson’s disease; essential tremor; progressive supranuclear palsy.

Recent Publications

Dr. Changiz Taghibiglou
Department of Pharmacology
(306) 966-8816
changiz.taghibiglou@usask.ca

Dr. Taghibiglou studies excitotoxicity in stroke and neurodegenerative diseases, and lipid neurobiology. Interests: stroke; epilepsy; traumatic brain injury; breast and prostate cancer; Cellular prion protein; lipid rafts; designing short bioactive peptides.

Recent Publications

Dr. Jose Tellez-Zenteno
Department of Medicine-Neurology
(306) 966-8011
jose.tellez@usask.ca

Dr. Tellez-Zenteno explores clinical outcomes after epilepsy surgery, management of antiepileptic drug use, and the development and validation of new diagnostic tools for epilepsy. Interests: temporal lobe epilepsy, epilepsy surgery; epidemiology of epilepsy.

Recent Publications

Dr. Wolfgang Walz
Department of Psychiatry
(306) 966-7618
wolfgang.walz@usask.ca

Dr. Walz is focusing on a book project “Reactive Gliosis in Brain Plasticity” highlighting the state of affairs in this field and how it relates to repair processes in the whole body. The monograph will also summarize his own work in the past 42 years. It will be published by Springer Nature. Dr. Walz is active with this publishing company as series editor for “Neuromethods” with over 100 books published to date..

Recent Publications

YanboZhang

Dr. Yanbo Zhang (Neuroscience Cluster Executive)
Deparment of Psychiatry
(306)844-1312
yanbo.zhang@usask.ca

Dr. Yanbo Zhang’s research focuses on (1) the impacts of psychiatric medications and brain stimulation treatments on brain development and repair; (2) the gene-environmental interaction and its role in mental disorder development. Interests: schizophrenia, mood disorder, post stroke depression and cannabis and other substance addictions.

Recent publications